Pharma Deals Review, Vol 2008, No 96 (2008)

Font Size:  Small  Medium  Large

Sonus Finds Way Out through Merger with OncoGenex

Sally Mardikian PhD

Abstract


Sonus Pharmaceuticals has overcome disappointing Phase III failure in late 2007 by merging with OncoGenex to form OncoGenex Pharmaceuticals, a company with an array of promising oncology clinical candidates.

Full Text: pdf html

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.